Correlation Between Carmell Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Carmell Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carmell Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Carmell Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Carmell Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carmell Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carmell Therapeutics and Revelation Biosciences.
Diversification Opportunities for Carmell Therapeutics and Revelation Biosciences
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Carmell and Revelation is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Carmell Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Carmell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carmell Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Carmell Therapeutics i.e., Carmell Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Carmell Therapeutics and Revelation Biosciences
Assuming the 90 days horizon Carmell Therapeutics is expected to under-perform the Revelation Biosciences. In addition to that, Carmell Therapeutics is 2.7 times more volatile than Revelation Biosciences. It trades about -0.3 of its total potential returns per unit of risk. Revelation Biosciences is currently generating about -0.25 per unit of volatility. If you would invest 97.00 in Revelation Biosciences on September 13, 2024 and sell it today you would lose (55.00) from holding Revelation Biosciences or give up 56.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 36.36% |
| Values | Daily Returns |
Carmell Therapeutics vs. Revelation Biosciences
Performance |
| Timeline |
| Carmell Therapeutics |
| Revelation Biosciences |
Carmell Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Carmell Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Carmell Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carmell Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Carmell Therapeutics vs. Mediag3 | Carmell Therapeutics vs. LithiumBank Resources Corp | Carmell Therapeutics vs. Reservoir Media | Carmell Therapeutics vs. Arrow Financial |
| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |